Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Pharm Res. 2014 Feb;31(2):436–448. doi: 10.1007/s11095-013-1173-6

Table 4.

Summary of cumulative 42-day release and aggregation behavior of lysozyme from implants prepared from di-block copolymers blended with PLGA (50/50) at 1:1 weight ratio with or without 3% MgCO3.

Polymer Name Lysozyme (%) MgCO3 (%) Cumulative Release (%) Soluble Residue (%) Insoluble Aggregates (%) Recovery (%)
AB10-PLGA 15 0 100 ± 3 0.3 ± 0.1 5.9 ± 0.4 106 ± 3
AB10-PLGA 15 3 88 ± 1 0.6 ± 0.1 6.5 ± 0.5 95 ± 1
AB15-PLGA 15 0 71 ± 4 0.7 ± 0.2 14 ± 2 86 ± 4
AB15-PLGA 15 3 90 ± 4 0 2.9 ± 0.7 92 ± 4